Skip to main content
. Author manuscript; available in PMC: 2019 Aug 16.
Published in final edited form as: Clin Lymphoma Myeloma Leuk. 2018 Feb 2;18(3):180–190.e2. doi: 10.1016/j.clml.2018.01.004

Figure 1.

Figure 1

Consortium Diagram. *Histologic DLBCL Subtypes: Defined as Either GCB or ABC (Also Known as Post-GCB). By Immunophenotypic Criteria (GCB Type Was Considered When CD10 Was Expressed in > 30% of Cells, or if CD10−, BCL6+, and IRF4/MUM1−; All Others Were Considered to be ABC Type or Non-GC) Abbreviations: aa-IPI = age-adjusted International Prognostic Index; ABC = activated B–cell-like; DLBCL = diffuse large B-cell lymphoma; EPOCH = etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin; GCB germinal center B–cell-like; MTD = maximum tolerated dosage; QD = daily.